IBM and Medtronic to Partner to Improve Diabetes Care
April 13, 2015
ARMONK, NY and DUBLIN - April 13, 2015 - IBM (NYSE: IBM) and Medtronic (NYSE: MDT) today announced that they will work together to combine powerful analytics and cognitive computing with diabetes medical devices and health data to develop a new generation of personalized diabetes management solutions.
Medtronic Acquires Diabeter, Innovative Diabetes Care Provider
April 2, 2015
DUBLIN - April 2, 2015 - Medtronic plc (NYSE:MDT) today announced its acquisition of Diabeter, an innovative, independent Netherlands-based diabetes clinic and research center dedicated to providing comprehensive and individualized care for children and young adults with diabetes.
Diabetes Technology & Therapeutics Publishes Retrospective Analysis Detailing Impact of Threshold Suspend in Addressing Hypoglycemia
February 12, 2015
DUBLIN - February 12, 2015 - Medtronic plc (NYSE:MDT) today announced results of a retrospective analysis based on real-world data from over 20,000 MiniMed® 530G users, which found that the pump's Threshold Suspend feature reduced hypoglycemia, especially at night, without significantly increasing hyperglycemia.
Medtronic Completes Acquisition of Covidien
January 26, 2015
DUBLIN, Ireland –Medtronic plc (NYSE: MDT), a global leader in medical technology, services and solutions, announced today that it has successfully completed the previously announced acquisition of Covidien plc (NYSE: COV). Under the terms of the acquisition agreement, Medtronic, Inc. and Covidien plc are now combined under Medtronic plc. Shares of Medtronic plc are expected to begin trading on the New York Stock Exchange (NYSE) under the symbol “MDT” on Tuesday, January 27, 2015.
Medtronic Issues $250,000 in Health Access Grants to Support Diabetes Services for the Underserved of San Antonio
December 8, 2014
SAN ANTONIO, TX - December 8, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that five San Antonio community organizations will receive a combined $250,000 in Health Access Grants in recognition of their continued commitment to promoting healthy lifestyles and improving access to healthcare, with an emphasis on diabetes. As Medtronic marks the five year anniversary of its San Antonio location, this announcement demonstrates the company's ongoing support of the local community. Medtronic Philanthropy awards Health Access Grants in 36 communities around the world where Medtronic has a major presence.
For media inquiries pertaining to the Diabetes Group of Medtronic, please contact:
Director of Digital Marketing and Communications
For all other media inquiries please select the appropriate Global Public and Media Relations contact